Other analyses of patients receiving germline MGP genetic testing for cancer predisposition genes demonstrated that ATM PVs were associated with a moderate risk of breast cancer with an odds ratio (OR) of 2.03 or 2.78 [11,86]. This evidence concerns the gene ATM and breast carcinoma.